Status:
UNKNOWN
Impact of Influenza/RSV PCR Point-of-care Testing in the Emergency Medical Service.
Lead Sponsor:
University Hospital, Clermont-Ferrand
Conditions:
Influenza
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of the study is to compare Emergency Department patients who undergo influenza and RSV PCR testing using an FDA-approved point-of-care device (Cepheid Xpert® Xpress Flu/RSV) located in the...
Detailed Description
* This study will be conducted during the influenza's epidemic season. The start and the end of this study will be determined using national epidemic bases (national reference center for inluenza in L...
Eligibility Criteria
Inclusion
- Inclusion criteria :
- 18 years old and older
- coming in the emergency medical service
- during the influenza epidemic period
- with influenza symptoms
- whose support requires virologic confirmation
- people having given their consent
- Exclusion criteria :
- pregnant or breast feeding women
- patient unable to give consent
- tutorship or curatorship or under the protection of justice
- patient non registered in the social security system
Exclusion
Key Trial Info
Start Date :
January 17 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2019
Estimated Enrollment :
431 Patients enrolled
Trial Details
Trial ID
NCT04048369
Start Date
January 17 2019
End Date
December 31 2019
Last Update
August 7 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Clermont-Ferrand
Clermont-Ferrand, Auvergne, France, 63003